Huntington Disease Treatment Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
Huntington’s Disease Treatment Market Outlook
Huntington’s Disease Treatment Market is predicted to attain US$ 1,284.69 Million via 2030, consistent with Renub Research. Huntington’s disease is an extraordinary, genetic situation that results in the revolutionary destruction of mind nerve cells. The useful capacities of a person are considerably impacted by using Huntington’s disease, which usually reasons mobility, cognitive, and mental issues. It generally starts whilst a person is of their 30s or 40s. There is currently no authorized ailment-enhancing remedy for sufferers with Huntington’s sickness. The price at which signs and symptoms seem can vary from man or woman to man or woman. For a few humans, motor talent adjustments come first, observed by depressive symptoms. Changes in temper and peculiar conduct are common early caution signs.
The increase in incidences of Huntington ailment within the geriatric populace is propelling the Huntington disorder treatment market enlargement. Difficulty in strolling, disabled cognitive capacity and trouble in swallowing being the ailment’s signs and symptoms are more and more being found within the growing geriatric populace, prompting the need for excessive scientific interest. This is likewise encouraging substantial studies and developmental activities for designing more effective pills and launching of pipeline tablets. The surge in want for Huntington disease treatment is drawing its market increase based totally at the developing wide variety of cases of despair, an early symptom of the Huntington disease that is predicted to bolster the global Huntington disease remedy market growth. The surge in patient pool afflicted with genetic disorders and its rising attention among human beings are feasible causative elements with a purpose to impel the growth of the worldwide Huntington ailment remedy market. Furthermore, mergers and acquisitions amongst market key gamers are growing the traction for sales technology for the market. This is observed as an additional aspect escalating the global Huntington disorder treatment market expansion.
Huntington Disease Market will enjoy a steady growth rate of 16.53% in terms of compound annual growth fee (CAGR) from 2022 to 2030
CAG expansions inside the Huntingtin (Htt) gene purpose Huntington Disease (HD), affecting 1 in 10,000 individuals consistent with the CDC. HD sufferers show off CAG repeats from 36 to 200, contrasting with fewer than 35 in healthful people. Regional disparities make contributions to a tenfold variant in HD occurrence. Immunomodulatory tablets focused on the hyperactive immune reaction in HD are a key research attention. Market increase is expected with Ingrezza's label enlargement for chorea related to HD, Western international locations' excessive HD prevalence, and a sturdy pipeline of sickness-enhancing treatments.
In North America, HD influences approximately 30,000 humans (5.7 in keeping with 100,000), with uncommon pediatric cases (5%-10%). In Europe, it affects up to 10 individuals in line with 100,000. Research explores cell and gene-primarily based treatment options, neurogenesis, neuron regeneration, and reducing Huntingtin protein manufacturing as HD remedy techniques. Global Huntington disease Treatment Market was valued at US$ 377.73 Million in 2022.
Approved tablets are anticipated to dominate the market proportion in the Huntington's disorder Treatment Market
By Drug Type, Huntington sickness Treatment Market is split into Approved Drugs and Off-label Drugs. Approved capsules are poised to claim the largest market in the Huntington's disease Treatment Market. These medications have passed through rigorous trying out, assembly regulatory requirements and demonstrating their efficacy in managing the symptoms of this debilitating neurodegenerative disease. With the urgent need for healing answers for Huntington's disorder, physicians and patients often depend on these accredited treatments to relieve suffering and improve the first-rate of lifestyles.
Furthermore, set up capsules have a competitive gain in terms of accessibility and familiarity among healthcare vendors, ensuring their prominence inside the market. As studies maintain to discover novel remedies, accredited drugs remain a cornerstone within the treatment panorama, dominating the market for Huntington's sickness management.
The evolving landscape of healthcare delivery is driving the increase of drug shops and retail pharmacies as critical individuals to the Huntington's disease Treatment Market
By End User, Huntington sickness Treatment Market is split into Hospital Pharmacies, Drug Store & Retail Pharmacy and Online Pharmacy. The fastest-developing segment in the Huntington's disease Treatment Market is drug shops and retail pharmacies. This trend may be attributed to numerous elements. The increasing incidence of Huntington's sickness necessitates extra get right of entry to medicinal drugs for patients. Drug shops and retail pharmacies offer comfort, accessibility, and patient-pleasant offerings, making them preferred locations for individuals searching for treatment.
Moreover, the development of new medicines and treatment plans for Huntington's disorder, along with the expansion of accredited drug portfolios, has boosted demand for those stores. Patients can comfortably achieve prescribed medicinal drugs, including the ones for symptom control and disease-enhancing remedies, from these available locations.
United States Huntington Disease Treatment Market, likely to hold its top function inside the foreseeable destiny
By Country, Huntington disease Treatment Market is divided into United States, Canada, Germany, United Kingdom, France, Italy, Netherlands, Spain, China, South Korea, Japan, India, Indonesia, Malaysia, Argentina, Brazil, Mexico, Colombia, Saudi Arabia, South Africa, Israel, Australia, UAE and Rest of World. The United States boasts the highest market proportion within the Huntington's disease Treatment Market. The U.S. Has a robust healthcare infrastructure, together with global-famend studies establishments and healthcare facilities committed to neurological disorders. This fosters innovation and advances in Huntington's sickness treatment. The USA massive populace and excessive prevalence of Huntington's disease pressure market demand.
Additionally, the U.S. Pharmaceutical industry is a worldwide leader in developing and production tablets and cures for neurological situations, in addition solidifying its market dominance. The United States' leadership in research, treatment alternatives, and affected person care makes it a pivotal player within the worldwide Huntington's disease treatment market, probable to hold its pinnacle function within the foreseeable destiny.
Key Player
H Lundbeck, Pfizer Inc, Bausch Health Cos, Teva Pharmaceutical Industries, Dr Reddy's Laboratories, Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals Plc, Alnylam Pharmaceuticals, Novartis AG and UniQure are the outstanding agency running in the Huntington disease Treatment Market.
Renub Research report titled “Global Huntington’s Disease Treatment Market by Drug Type (Approved Drugs and Off-label Drugs), End-User (Hospital Pharmacies, Drug Store & Retail Pharmacy and Online Pharmacy), Region (North America (United States, Canada), Europe (Germany, United Kingdom, France, Italy, Netherlands and Spain), Asia Pacific (China, South Korea, Japan, Australia, India, Indonesia and Malaysia), Latin America (Argentina, Brazil, Mexico, Colombia), Middle East & Africa (Saudi Arabia, South Africa, Israel, UAE ) & ROW), Company Analysis (H Lundbeck, Pfizer Inc, Bausch Health Cos, Teva Pharmaceutical Industries, Dr Reddy's Laboratories, Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals Plc, Alnylam Pharmaceuticals, Novartis AG and UniQure)” provides a complete analysis of Global Huntington’s Disease Treatment Industry.
Drug Type – the Market has been covered from 2 viewpoints:
1. Approved Drugs
2. Offlabel Drugs
End User – the Market has been covered from 4 viewpoints:
1. Hospital Pharmacies
2. Drug Store & Retail Pharmacy
3. Online Pharmacy
Region – the Market has been covered from 6 viewpoints:
1. North America
1.1 United States
1.2 Canada
2. Europe
2.1 Germany
2.2 United Kingdom
2.3 France
2.4 Italy
2.5 Netherlands
2.6 Spain
3. Asia Pacific
3.1 China
3.2 South Korea
3.3 Japan
3.4 India
3.5 Indonesia
3.6 Malaysia
3.7 Australia
4. Latin America
4.1 Argentina
4.2 Brazil
4.3 Mexico
4.4 Colombia
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 Israel
5.4 South Africa
6. Rest of World
Company Insights:
• Overview
• Recent Development
• Revenue
Company Analysis:
1. H Lundbeck
2. Pfizer Inc.
3. Bausch Health Cos
4. Teva Pharmaceutical Industries
5. Dr Reddy's Laboratories
6. Sun Pharmaceutical Industries Limited
7. Hikma Pharmaceuticals Plc
8. Alnylam Pharmaceuticals
9. Novartis AG
10. UniQure
Report Details:
| Report Features | Details |
| Base Year | 2022 |
| Historical Period | 2018 - 2022 |
| Forecast Period | 2023 - 2030 |
| Market | US$ Million |
| Segment Covered | Drug Type, End User, and Countries |
| Countries Covered | United States, Canada, Germany, United Kingdom, France, Italy, Netherlands, Spain, China, South Korea, Japan, India, Indonesia, Malaysia, Australia, Argentina, Brazil, Mexico, Colombia, Saudi Arabia, UAE, Israel, South Africa and Rest of World |
| Companies Covered | H Lundbeck, Pfizer Inc, Bausch Health Cos, Teva Pharmaceutical Industries, Dr Reddy's Laboratories, Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals Plc, Alnylam Pharmaceuticals, Novartis AG and UniQure |
| Customization Scope | 20% Free Customization |
| Post-Sale Analyst Support | 1 Year (52 Weeks) |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Huntington’s Disease Treatment Market
6. Share Analysis – GlobalHuntington’s Disease Treatment Market
6.1 By Drug Type
6.2 By End User
6.3 By Country
7. Drug Type – Global Huntington’s Disease Treatment Market
7.1 Approved Drugs
7.2 Offlabel Drugs
8. End User – Global Huntington’s Disease Treatment Market
8.1 Hospital Pharmacy
8.2 Drug Store & Retail Pharmacy
8.3 Online Pharmacy
9. Country – Global Huntington’s Disease Treatment Market
9.1 North America
9.1.1 United States
9.1.2 Canada
9.2 Europe
9.2.1 Germany
9.2.2 United Kingdom
9.2.3 France
9.2.4 Italy
9.2.5 Netherlands
9.2.6 Spain
9.3 Asia Pacific
9.3.1 China
9.3.2 South Korea
9.3.3 Japan
9.3.4 India
9.3.5 Indonesia
9.3.6 Malaysia
9.3.7 Australia
9.4 Latin America
9.4.1 Argentina
9.4.2 Brazil
9.4.3 Mexico
9.4.4 Colombia
9.5 Middle East & Africa
9.5.1 Saudi Arabia
9.5.2 UAE
9.5.3 Israel
9.5.4 South Africa
9.6 Rest of World
10. Porter’s Five Forces Analysis – Global Huntington Disease Treatment Market
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes
11. SWOT Analysis – Global Huntington Disease Treatment Market
11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threat
12. Key Players
12.1 H Lundbeck
12.1.1 Overview
12.1.2 Recent Development
12.1.3 Revenue
12.2 Pfizer Inc.
12.2.1 Overview
12.2.2 Recent Development
12.2.3 Revenue
12.3 Bausch Health Cos
12.3.1 Overview
12.3.2 Recent Development
12.3.3 Revenue
12.4 Teva Pharmaceutical Industries
12.4.1 Overview
12.4.2 Recent Development
12.4.3 Revenue
12.5 Dr Reddy's Laboratories
12.5.1 Overview
12.5.2 Recent Development
12.5.3 Revenue
12.6 Sun Pharmaceutical Industries Limited
12.6.1 Overview
12.6.2 Recent Development
12.6.3 Revenue
12.7 Hikma Pharmaceuticals Plc
12.7.1 Overview
12.7.2 Recent Development
12.7.3 Revenue
12.8 Alnylam Pharmaceuticals
12.8.1 Overview
12.8.2 Recent Development
12.8.3 Revenue
12.9 Novartis AG
12.9.1 Overview
12.9.2 Recent Development
12.9.3 Revenue
12.10 UniQure
12.12.1 Overview
12.12.2 Recent Development
12.12.3 Revenue
List of Figures:
Figure-01: Global – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-02: Global – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-03: Drug Type – Approved Drugs Market (Million US$), 2018 – 2022
Figure-04: Drug Type – Forecast for Approved Drugs Market (Million US$), 2023 – 2030
Figure-05: Drug Type – Offlabel Drugs Market (Million US$), 2018 – 2022
Figure-06: Drug Type – Forecast for Offlabel Drugs Market (Million US$), 2023 – 2030
Figure-07: End User – Hospital Pharmacy Market (Million US$), 2018 – 2022
Figure-08: End User – Forecast for Hospital Pharmacy Market (Million US$), 2023 – 2030
Figure-09: End User – Drug Store & Retail Pharmacy Market (Million US$), 2018 – 2022
Figure-10: End User – Forecast for Drug Store & Retail Pharmacy Market (Million US$), 2023 – 2030
Figure-11: End User – Online Pharmacy Market (Million US$), 2018 – 2022
Figure-12: End User – Forecast for Online Pharmacy Market (Million US$), 2023 – 2030
Figure-13: United States – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-14: United States – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-15: Canada – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-16: Canada – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-17: Germany – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-18: Germany – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-19: United Kingdom – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-20: United Kingdom – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-21: France – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-22: France – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-23: Italy – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-24: Italy – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-25: Netherlands – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-26: Netherlands – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-27: Spain – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-28: Spain – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-29: China – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-30: China – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-31: South Korea – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-32: South Korea – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-33: Japan – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-34: Japan – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-35: India – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-36: India – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-37: Indonesia – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-38: Indonesia – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-39: Malaysia – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-40: Malaysia – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-41: Australia – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-42: Australia – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-43: Argentina – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-44: Argentina – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-45: Brazil – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-46: Brazil – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-47: Mexico – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-48: Mexico – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-49: Colombia – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-50: Colombia – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-51: Saudi Arabia – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-52: Saudi Arabia – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-53: UAE – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-54: UAE – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-55: Israel – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-56: Israel – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-57: South Africa – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-58: South Africa – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-59: Rest of World – Huntington’s Disease Treatment Market (Million US$), 2018 – 2022
Figure-60: Rest of World – Forecast for Huntington’s Disease Treatment Market (Million US$), 2023 – 2030
Figure-61: H Lundbeck – Global Revenue (Million US$), 2018 – 2022
Figure-62: H Lundbeck – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-63: Pfizer Inc. – Global Revenue (Million US$), 2018 – 2022
Figure-64: Pfizer Inc. – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-65: Bausch Health Cos – Global Revenue (Million US$), 2018 – 2022
Figure-66: Bausch Health Cos – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-67: Teva Pharmaceutical Industries – Global Revenue (Million US$), 2018 – 2022
Figure-68: Teva Pharmaceutical Industries – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-69: Dr Reddy's Laboratories – Global Revenue (Million US$), 2018 – 2022
Figure-70: Dr Reddy's Laboratories – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-71: Sun Pharmaceutical Industries Limited – Global Revenue (Million US$), 2018 – 2022
Figure-72: Sun Pharmaceutical Industries Limited – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-73: Hikma Pharmaceuticals Plc – Global Revenue (Million US$), 2018 – 2022
Figure-74: Hikma Pharmaceuticals Plc – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-75: Alnylam Pharmaceuticals – Global Revenue (Million US$), 2018 – 2022
Figure-76: Alnylam Pharmaceuticals – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-77: Novartis AG – Global Revenue (Million US$), 2018 – 2022
Figure-78: Novartis AG – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-79: UniQure – Global Revenue (Million US$), 2018 – 2022
Figure-80: UniQure – Forecast for Global Revenue (Million US$), 2023 – 2030
List of Tables:
Table-01: Global – Huntington’s Disease Treatment Market Share by Drug Type (Percent), 2018 – 2022
Table-02: Global – Forecast for Huntington’s Disease Treatment Market Share by Drug Type (Percent), 2023 – 2030
Table-03: Global – Huntington’s Disease Treatment Market Share by End User (Percent), 2018 – 2022
Table-04: Global – Forecast for Huntington’s Disease Treatment Market Share by End User (Percent), 2023 – 2030
Table-05: Global – Huntington’s Disease Treatment Market Share by Countries (Percent), 2018 – 2022
Table-06: Global – Forecast for Huntington’s Disease Treatment Market Share by Countries (Percent), 2023 – 2030
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com